Insider Trading & Ownership of Blaine Davis
-
Location
-
New York, NY
-
Summary
-
The estimated net worth of Blaine Davis is at least $866,148 dollars as of 08 Jan 2026. Blaine Davis is the Chief Financial Officer of Cartesian Therapeutics, Inc. and owns shares of Cartesian Therapeutics, Inc. (RNAC) stock worth about $826.7K. Blaine Davis is the Chief Financial Officer of Protara Therapeutics, Inc. and owns shares of Protara Therapeutics, Inc. (TARA) stock worth about $39.5K.
-
Signature
-
/s/ Matthew Bartholomae, Attorney-in-Fact for Blaine Davis
Follow Filing Activity
Follow Blaine Davis and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Quick Takeaways
- Blaine Davis has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $866,148.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: Cartesian Therapeutics, Inc. ($826,684).
- Past-year value change for that position: -$72,227.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Blaine Davis
Insider Transactions Reported by Blaine Davis:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.